NO20032261L - Medisinske preparater - Google Patents

Medisinske preparater

Info

Publication number
NO20032261L
NO20032261L NO20032261A NO20032261A NO20032261L NO 20032261 L NO20032261 L NO 20032261L NO 20032261 A NO20032261 A NO 20032261A NO 20032261 A NO20032261 A NO 20032261A NO 20032261 L NO20032261 L NO 20032261L
Authority
NO
Norway
Prior art keywords
compounds
pharmacologically acceptable
pharmaceutical composition
esters
acceptable salts
Prior art date
Application number
NO20032261A
Other languages
English (en)
Other versions
NO20032261D0 (no
NO332938B1 (no
Inventor
Toshio Sada
Makoto Mizuno
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26604360&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20032261(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO20032261D0 publication Critical patent/NO20032261D0/no
Publication of NO20032261L publication Critical patent/NO20032261L/no
Publication of NO332938B1 publication Critical patent/NO332938B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Farmasøytisk preparat omfattende en angiotensin II-reseptor-antagonist valgt blant forbindelser med den generelle formel (I):. farmakologisk aksepterbare salter av forbindelsene, farmakologisk aksepterbare estere av forbindelsene og farmakologisk aksepterbare salter av de nevnte estere, samt ett eller flere diuretika. Det farmasøytiske preparat ifølge oppfinnelsen oppviser utmerket hypotensiv virkning og har lav toksisitet, og det er derfor anvendelig som et legemiddel for forebygging eller behandling av hypertensjon eller hjertesykdommer.
NO20032261A 2000-11-21 2003-05-20 Farmasoytisk preparat som inneholder en spesifikk angiotensin II-reseptor-antagonist og hydroklortiazid, og anvendelsen derav for fremstilling av det farmasoytiske medikament for forebygging eller behandling av hypertensjon hos varmblodige dyr NO332938B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000354327 2000-11-21
JP2001164009 2001-05-31
PCT/JP2001/010095 WO2002041890A1 (en) 2000-11-21 2001-11-19 Medicinal compositions

Publications (3)

Publication Number Publication Date
NO20032261D0 NO20032261D0 (no) 2003-05-20
NO20032261L true NO20032261L (no) 2003-07-09
NO332938B1 NO332938B1 (no) 2013-02-04

Family

ID=26604360

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032261A NO332938B1 (no) 2000-11-21 2003-05-20 Farmasoytisk preparat som inneholder en spesifikk angiotensin II-reseptor-antagonist og hydroklortiazid, og anvendelsen derav for fremstilling av det farmasoytiske medikament for forebygging eller behandling av hypertensjon hos varmblodige dyr

Country Status (23)

Country Link
US (2) US6878703B2 (no)
EP (2) EP1336407B1 (no)
KR (1) KR100656716B1 (no)
CN (1) CN1265788C (no)
AT (1) ATE324890T1 (no)
AU (2) AU2002214324B2 (no)
BR (1) BR0115516A (no)
CA (1) CA2429260A1 (no)
CY (1) CY1106134T1 (no)
CZ (1) CZ20031367A3 (no)
DE (1) DE60119368T2 (no)
DK (1) DK1336407T3 (no)
ES (1) ES2262689T3 (no)
HU (1) HUP0400553A3 (no)
IL (2) IL155965A0 (no)
MX (1) MXPA03004463A (no)
NO (1) NO332938B1 (no)
NZ (1) NZ525913A (no)
PL (1) PL207252B1 (no)
PT (1) PT1336407E (no)
SK (1) SK5992003A3 (no)
TW (1) TWI262076B (no)
WO (1) WO2002041890A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS20050590A (sr) * 2003-01-31 2007-09-21 Sankyo Company Limited, Lek za profilaksu i tretman arterioskleroze i hipertenzije
US20040198789A1 (en) * 2003-02-28 2004-10-07 Recordati Ireland Limited Lercanidipine/ARB/diuretic therapeutic combinations
JP2007504136A (ja) 2003-08-28 2007-03-01 ニトロメッド インコーポレーティッド ニトロソ化およびニトロシル化利尿化合物、組成物、ならびに使用方法
CN1993355A (zh) * 2004-09-02 2007-07-04 特瓦制药工业有限公司 奥美沙坦酯的纯化方法
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
WO2006029057A1 (en) * 2004-09-02 2006-03-16 Teva Pharmaceutical Industries, Ltd. Purification of olmesartan medoxomil
WO2006091716A2 (en) 2005-02-24 2006-08-31 Nitromed, Inc. Nitric oxide enhancing diuretic compounds, compositions and methods of use
TWI367755B (en) * 2005-05-20 2012-07-11 Sankyo Co Film coated product
KR101314439B1 (ko) * 2005-05-20 2013-10-07 다이이찌 산쿄 가부시키가이샤 덱스트로오스 함유 필름 코팅 제제
WO2007047838A2 (en) * 2005-10-20 2007-04-26 Dr. Reddy's Laboratories Ltd. Process for preparing olmesartan medoxomil
US8077769B2 (en) * 2006-03-28 2011-12-13 Sony Corporation Method of reducing computations in transform and scaling processes in a digital video encoder using a threshold-based approach
EP1891952B1 (en) * 2006-05-04 2011-10-05 LEK Pharmaceuticals d.d. Pharmaceutical composition of olmesartan medoxomil
CN101534798B (zh) * 2006-10-30 2012-02-15 韩诺生物制约株式会社 包含噻嗪类和血管紧张素ⅱ受体阻断剂的控释药物组合物
ES2510866T3 (es) 2008-03-13 2014-10-21 Daiichi Sankyo Company, Limited Mejora de la solubilidad de una preparación que contiene olmesartán medoxomilo
US20100008956A1 (en) * 2008-07-08 2010-01-14 Jie Du Composition and combinations of carboxylic acid losartan in dosage forms
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
WO2010075347A2 (en) 2008-12-23 2010-07-01 Takeda Pharmaceutical Company Limited Methods of treating hypertension with at least one angiotensin ii receptor blocker and chlorthalidone
IT1400311B1 (it) 2010-05-10 2013-05-24 Menarini Int Operations Lu Sa Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso.
WO2019241590A1 (en) 2018-06-14 2019-12-19 Astrazeneca Uk Limited Methods for treatment of hypertension with an angiotensin ii receptor blocker pharmaceutical composition

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2783241A (en) 1957-02-26 S-acylimino-x-substituted-az-i
US3254076A (en) 1966-05-31 Sulfamyl hydro
US3108097A (en) 1963-10-22 Ehnojs
US2976289A (en) 1961-03-21 X-tetrahydro -
US3025292A (en) 1962-03-13 Reduction of i
US3009911A (en) 1961-11-21 Derivatives of j
US2554816A (en) 1950-04-04 1951-05-29 American Cyanamid Co Heterocyclic sulfonamides and methods of preparation thereof
GB795174A (en) 1954-10-13 1958-05-21 Upjohn Co Heterocyclic sulphonamides
US2835702A (en) 1956-05-02 1958-05-20 Merck & Co Inc Benzene 1, 3 disulfonamides possessing diuretic properties
US2980679A (en) 1957-04-04 1961-04-18 Omikron Gagliardi Societa Di F Process for preparing heterocyclic sulfonamides
US3055904A (en) 1957-11-04 1962-09-25 Geigy Chem Corp New isoindoline derivatives
GB851287A (en) 1958-07-10 1960-10-12 British Drug Houses Ltd 5-chlorotoluene-2:4-disulphonamide and alkali metal salts thereof
US3058882A (en) 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3255241A (en) 1961-01-19 1966-06-07 Merck & Co Inc (2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids
GB979994A (en) 1961-07-28 1965-01-06 May & Baker Ltd Isoindolinone derivatives
US3265573A (en) 1962-07-27 1966-08-09 Squibb & Sons Inc Benzothiadiazinesulfonamide-1, 1-dioxide composition
BE639386A (no) 1962-10-30
DE1278443C2 (de) 1963-11-30 1975-07-24 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 2,4-disulfonamid-1-chlorbenzolen
US3163645A (en) 1964-09-25 1964-12-29 Ciba Geigy Corp Derivatives of 3, 4-dihydro-2-h-[1, 2, 4]-benzothiadiazine-1, 1-dioxides
DE1270544B (de) 1965-06-19 1968-06-20 Beiersdorf Ag 4-Chlor-5-sulfamylsalicylsaeure-(2', 6'-dimethyl)-anilid und dessen Alkali- oder Ammonium-Salze sowie Verfahren zu deren Herstellung
US3360518A (en) 1966-01-03 1967-12-26 Wallace & Tiernan Inc Tetrahydro-halo-sulfamyl quinazolinones
US3634583A (en) 1969-07-24 1972-01-11 Leo Pharm Prod Ltd Pharmaceutical composition for the treatment of oedematous conditions and hypertension
BE757001A (fr) 1969-10-10 1971-03-16 Cerpha Derives heterocycliques d'acides phenoxy acetique et leur preparation
US5138069A (en) 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
EP0733366B1 (en) * 1988-01-07 1998-04-01 E.I. Du Pont De Nemours And Company Pharmaceutical compositions comprising angiotensin II receptor blocking imidazoles and diuretics
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
EP0400835A1 (en) * 1989-05-15 1990-12-05 Merck & Co. Inc. Substituted benzimidazoles as angiotensin II antagonists
US5656650A (en) * 1990-12-14 1997-08-12 Smithkline Beecham Corp. Angiotensin II receptor blocking compositions
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
CA2229000C (en) * 1991-02-21 2002-04-09 Sankyo Company, Limited 1-biphenylimidazole derivatives, their preparation and their therapeutic use
US5310928A (en) 1991-11-18 1994-05-10 E. I. Du Pont De Nemours And Company Process for preparing biphenyltetrazole compounds
US5264447A (en) * 1992-09-01 1993-11-23 Merck & Co., Inc. Angiotensin II antagonist

Also Published As

Publication number Publication date
AU1432402A (en) 2002-06-03
EP1595540A1 (en) 2005-11-16
EP1336407A1 (en) 2003-08-20
DE60119368T2 (de) 2007-05-03
HK1054692A1 (en) 2003-12-12
NO20032261D0 (no) 2003-05-20
IL155965A (en) 2008-08-07
PL207252B1 (pl) 2010-11-30
EP1336407B1 (en) 2006-05-03
KR100656716B1 (ko) 2006-12-13
KR20030096235A (ko) 2003-12-24
US20040002529A1 (en) 2004-01-01
ATE324890T1 (de) 2006-06-15
CN1486182A (zh) 2004-03-31
CA2429260A1 (en) 2002-05-30
SK5992003A3 (en) 2003-11-04
CN1265788C (zh) 2006-07-26
MXPA03004463A (es) 2003-08-19
US20050113367A1 (en) 2005-05-26
CY1106134T1 (el) 2011-06-08
HUP0400553A2 (hu) 2004-06-28
BR0115516A (pt) 2004-02-03
EP1336407A4 (en) 2004-07-14
CZ20031367A3 (cs) 2003-10-15
TWI262076B (en) 2006-09-21
IL155965A0 (en) 2003-12-23
PT1336407E (pt) 2006-07-31
WO2002041890A1 (en) 2002-05-30
HUP0400553A3 (en) 2010-03-29
AU2002214324B2 (en) 2004-07-29
NO332938B1 (no) 2013-02-04
US6878703B2 (en) 2005-04-12
NZ525913A (en) 2004-05-28
ES2262689T3 (es) 2006-12-01
PL361093A1 (en) 2004-09-20
DK1336407T3 (da) 2006-09-04
DE60119368D1 (de) 2006-06-08

Similar Documents

Publication Publication Date Title
MXPA05008142A (es) Medicamento para la profilaxis y el tratamiento de arteriosclerosis e hipertension.
NO20032261D0 (no) Medisinske preparater
NO20081970L (no) Sulfonamidderivat med PGD2-reseptorantagonistaktivitet
NO20051008L (no) Nye imidazolforbindelser som transformerende vekst faktor (TGF) inhibitorer
EE200300403A (et) N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina
NO20000572D0 (no) Indolderivater som MCP-1 reseptor antagonister
IS8502A (is) Azatvíhringja heteróhringir sem kannabínóíð-viðtakastillar
MXPA04005209A (es) Antagonistas del receptor de adenosina a2a.
EA200600811A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ
NO20071314L (no) Peptidiske vasopressinreseptoragonister
WO2002085909A8 (en) 9-deazaguanine derivatives as inhibitors of gsk-3
NO20060195L (no) Kinolylamidderivater som CCR-5-antagonister
NO20040881L (no) Orale antidiabetes midler.
NO20071321L (no) Anti-inflammatoriske midler
NO973652D0 (no) 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyre og derivater som tachykininreseptor-antagonist
DK1228758T3 (da) Anvendelse af sulfodehydroabietinsyre til behandling af inflammatorisk tarmsygdom
TR199800165T1 (xx) (R)-5-bromo-n-(1-etil-4-metil hekzahidro-1h-1,4-diazepin-6-il)-2-metoksi-6- metilamino-3-piridinkarboksamid, bunu haz�rlamaya mahsus y�ntem ve bu bile�i�i ihtiva eden farmas�tik terkip.
ATE326451T1 (de) Chinazolin derivate und therapeutische verwendungen davon
NO20050903L (no) Nye piperazinyl-pyrazinonderivater for behandling av 5HT-2A reseptorrelaterte forstyrrelser
IS8096A (is) Notkun karbamasepínafleiða til að meðhöndla órósemi í sjúklingum er þjást af vitglöpum
TW200509915A (en) Novel oxazoles, their manufacture and use as pharmaceutical agents
NO20054020L (no) Medisin for forhindring og behandling av arterosklerose og hypertensjon
ATE301997T1 (de) Antivirale therapie
WO2003004019A8 (en) Use of heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin a for the treatment of beta-thalassaemia
NO20080947L (no) Terapeutisk middel for hypertensjon

Legal Events

Date Code Title Description
MK1K Patent expired